Your browser doesn't support javascript.
loading
Key considerations for the use of artificial intelligence in healthcare and clinical research.
Lovejoy, Christopher A; Arora, Anmol; Buch, Varun; Dayan, Ittai.
Afiliación
  • Lovejoy CA; University College London, London, UK and University College Hospital, London, UK.
  • Arora A; University of Cambridge, Cambridge, UK and honorary research fellow, Moorfields Eye Hospital, London UK.
  • Buch V; MGH & BWH Center for Clinical Data Science, Boston, USA.
  • Dayan I; Partners HealthCare, Boston, USA and chief executive officer, Rhino Health, Boston, USA.
Future Healthc J ; 9(1): 75-78, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35372779
Interest in artificial intelligence (AI) has grown exponentially in recent years, attracting sensational headlines and speculation. While there is considerable potential for AI to augment clinical practice, there remain numerous practical implications that must be considered when exploring AI solutions. These range from ethical concerns about algorithmic bias to legislative concerns in an uncertain regulatory environment. In the absence of established protocols and examples of best practice, there is a growing need for clear guidance both for innovators and early adopters. Broadly, there are three stages to the innovation process: invention, development and implementation. In this paper, we present key considerations for innovators at each stage and offer suggestions along the AI development pipeline, from bench to bedside.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Aspecto: Ethics Idioma: En Revista: Future Healthc J Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Aspecto: Ethics Idioma: En Revista: Future Healthc J Año: 2022 Tipo del documento: Article
...